1 active not recruiting, 1 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 1, Completed 1 |
Follow BRVO - Branch Retinal Vein Occlusion: new trials by email Literature Review of BRVO - Branch Retinal Vein Occlusion trials Research Report on BRVO - Branch Retinal Vein Occlusion
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A 3-month Study to Compare the Safety of ONS-5010 in Vials Versus Pre-filled Syringe in Subjects With Visual Impairment Due to Retinal Disorders bevacizumab - Age-Related Macular Degeneration, Neovascular Age-related Macular Degeneration | Phase 3 | Active not recruiting | Outlook Therapeutics, Inc. | 120 | 2021-11-15 | 2026-04-22 |
| A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders bevacizumab - Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration | Phase 3 | Completed | Outlook Therapeutics, Inc. | 197 | 2020-10-01 | 2026-07-17 |
Macular Degeneration (2) · Retinal Vein Occlusion (2) · Wet Macular Degeneration (2)
Cardiovascular Diseases (2) · Embolism and Thrombosis (2) · Eye Diseases (2) · Retinal Degeneration (2) · Retinal Diseases (2) · Thrombosis (2) · Vascular Diseases (2) · Venous Thrombosis (2)
Bevacizumab (2)
Outlook Therapeutics, Inc. (2)
United States (2)